About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Immediate Breast Reconstruction With Acellular Dermal Matrix

NCT04209010·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Aarhus University Hospital

With

Danish Cancer Society
The Korning foundation
Foundation of the Kjaersgaard Family
King Christian X foundation
Foundation of architect Holger Hjortenberg
LifeCell Corporation (Branchburg, NJ, USA)

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Skin sparing mastectomy due to breast cancer, ductal carcinoma in situ or high genetic risk of developing breast cancer
Mastectomy weight ≤ 600 g
Patient older than 18 years
Ability to complete the study questionnaire
Only for the two-stage group no later than 2 years and 4 months from breast reconstruction

You may not be if

\- smokers

The record

StatusCompleted

PhaseNo phase

Taking part44

StartedDec 2012

UpdatedJan 3, 2020

Conditions

Breast Cancer Breast Carcinoma in Situ Mammaplasty Acellular Dermis

Clareo Health | Immediate Breast Reconstruction With Acellular Dermal Matrix